Investors Research Corp’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-35,625
Closed -$17K 1176
2022
Q2
$17K Hold
35,625
0.01% 688
2022
Q1
$82K Buy
35,625
+3,100
+10% +$9.09K 0.02% 452
2021
Q4
$122K Sell
32,525
-5,500
-14% -$26.6K 0.04% 373
2021
Q3
$123K Hold
38,025
0.04% 372
2021
Q2
$178K Hold
38,025
0.06% 309
2021
Q1
$282K Sell
38,025
-600
-2% -$4.86K 0.11% 252
2020
Q4
$277K Hold
38,625
0.11% 259
2020
Q3
$127K Sell
38,625
-700
-2% -$2.25K 0.06% 341
2020
Q2
$135K Hold
39,325
0.07% 318
2020
Q1
$146K Hold
39,325
0.09% 276
2019
Q4
$184K Hold
39,325
0.08% 301
2019
Q3
$126K Sell
39,325
-600
-2% -$1.94K 0.06% 348
2019
Q2
$164K Buy
39,925
+200
+0.5% +$1.26K 0.09% 286
2019
Q1
$319K Hold
39,725
0.17% 183
2018
Q4
$290K Hold
39,725
0.2% 186
2018
Q3
$669K Sell
39,725
-1,300
-3% -$18.5K 0.38% 97
2018
Q2
$387K Buy
41,025
+700
+2% +$4.71K 0.22% 170
2018
Q1
$240K Buy
40,325
+4,500
+13% +$31.5K 0.15% 244
2017
Q4
$278K Buy
+35,825
New +$268K 0.17% 216

Other funds holding ENDP

Investors Research Corp's ENDP Position: Q3 2022 in Review

Investors Research Corp sold out of Endo International plc (ENDP) in Q3 2022, closing a stake of 35,625 shares — an estimated $17K sold.

Investors Research Corp first reported a position in ENDP in Q4 2017 and held it in 19 quarters. The position peaked at $669K in Q3 2018. 12 funds tracked by Wall St. Rank hold ENDP as of Q3 2022.

  • Investors Research Corp reported no remaining Endo International plc position as of Q3 2022 after selling out during the quarter.
  • Investors Research Corp sold 35,625 Endo International plc shares in Q3 2022, an estimated $17K.
  • Investors Research Corp first reported a position in Endo International plc in Q4 2017 and held it in 19 quarters.
  • Investors Research Corp's Endo International plc position peaked at $669K in Q3 2018.
  • 12 funds tracked by Wall St. Rank held Endo International plc as of Q3 2022.

Based on Investors Research Corp's 13F filing for Q3 2022, filed 10 Nov 2022.